In a study of 4331 tumours with known HER2/CEP17 ratio, HER2 copy number and HER2 IHC status, Press et al.20 identified only 35 Group 2 tumours, of which only three displayed an IHC 2+ score. Here, ERBB2 is linked to neoplasm.